Weight Loss Medication Online

GLP-1 medications are prescription treatments that mimic the glucagon-like peptide-1 hormone your gut releases after eating. They reduce appetite, slow stomach emptying, and support blood sugar control, which together help many people lose weight when combined with diet and activity. Semaglutide and tirzepatide are the two most widely used.

There is no single best option for everyone. A licensed provider recommends the option that fits your health history and goals.

Semaglutide activates GLP-1 receptors. Tirzepatide activates both GIP and GLP-1 receptors. Both are offered here as once-weekly compounded injections and as needle-free oral options.

Yes. Compounded oral semaglutide and oral tirzepatide are daily, needle-free options for people who prefer to avoid injections. A provider can explain differences in absorption and dosing versus the weekly injectables.

Yes. Every GLP-1 treatment on DripVitals requires a valid prescription issued by a licensed provider after an online review. None are available over the counter.

No. DripVitals plans are cash-pay and do not bill insurance, and compounded medications are generally not covered by insurance. Your plan price is shown upfront before you check out.

Nausea, diarrhea, constipation, vomiting, and stomach discomfort are the most common, especially during dose changes, and usually ease over time. Each product page has a detailed safety section, and GLP-1s carry a boxed warning regarding thyroid C-cell tumors.

Complete a short online health questionnaire, get reviewed by a licensed provider, and if approved your medication ships from a licensed pharmacy. You can also check your BMI first to see where you stand.

No. Compounded semaglutide and compounded tirzepatide are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed. A licensed provider determines whether a compounded medication is appropriate for your individual medical needs.

The FDA has received reports of dosing errors with compounded injectable semaglutide, often related to drawing up doses from vials with syringes or confusing units and milliliters. To reduce risk, follow your provider’s written dosing instructions exactly, use only the supplies provided, never adjust your dose on your own, and ask your provider or pharmacist before injecting if anything is unclear.

Eligibility is determined by a licensed provider based on your full health picture. GLP-1 weight-management treatment is typically considered for adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition. Checking your BMI takes under a minute and helps frame the conversation, but the provider makes the final call.

Tell both your GLP-1 provider and your surgical or anesthesia team that you take a GLP-1 medication before any surgery, procedure, general anesthesia, or deep sedation. Because GLP-1s slow stomach emptying, they have been associated with rare reports of pulmonary aspiration during procedures under general anesthesia or deep sedation, and your care team may adjust timing or give special fasting instructions.

Sometimes, with provider guidance. People switch for reasons like plateaued progress, side effects, or cost, and a licensed provider determines whether a switch is appropriate, what the equivalent starting dose should be, and how to transition safely. Never switch or combine GLP-1 medications on your own.